Applied DNA Sciences, Inc. Stock

$4.63

6.19%

Nasdaq, Jul 03, 10:21 pm CET

ISIN

US03815U2015

Symbol

APDN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Technology

Industry

IT Services

Overview Dividends Analysts Charts News Strategies

Applied DNA Sciences, Inc. Stock price

$4.63

-123,745.37 100.00% 5Y

Nasdaq, Closing price Thu, Jul 03 2025

-0.31 6.19%

ISIN

US03815U2015

Symbol

APDN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Technology

Industry

IT Services

Key metrics

Basic

Market capitalization

$2.4m

Enterprise Value

$-4.4m

Net debt

positive

Cash

$6.8m

Shares outstanding

420.0k

Valuation (TTM | estimate)

P/E

negative | negative

P/S

0.6 | 0.4

EV/Sales

negative | negative

EV/FCF

0.3

P/B

0.2

Financial Health

Equity Ratio

71.5%

Return on Equity

-79.0%

ROCE

-117.0%

ROIC

Debt/Equity

0.0

Financials (TTM | estimate)

Revenue

$3.8m | $5.4m

EBITDA

$-12.7m | -

EBIT

$-13.0m | $-11.9m

Net Income

$-46.2m | $-154.2m

Free Cash Flow

$-14.0m

Growth (TTM | estimate)

Revenue

-31.3% | 57.1%

EBITDA

4.6% | -

EBIT

9.6%

Net Income

-269.5% | -2,033.1%

Free Cash Flow

-15.1%

EPS

$-390.7

FCF per Share

$-33.2

Short interest

20.1%

Employees

Rev per Employee

$70.0k

As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.

Get Started for Free Today

Applied DNA Sciences, Inc. Stock Analysis

Unlock Scores for Free

??

6 Analysts have issued a Applied DNA Sciences, Inc. forecast:

3x Hold

50%

3x Sell

50%

More details on Analyst Estimates Including Price Targets

6 Analysts have issued a Applied DNA Sciences, Inc. forecast:

Hold

50%

Sell

50%

Analyst Estimates with Stock Price Targets

Financial data from Applied DNA Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	3.79 3.79	31% 31% 100%
- Direct Costs	2.25 2.25	38% 38% 59%
Gross Profit	1.55 1.55	18% 18% 41%
- Selling and Administrative Expenses	11 11	13% 13% 290%
- Research and Development Expense	3.61 3.61	0% 0% 95%
EBITDA	-13 -13	5% 5% -334%
- Depreciation and Amortization	0.39 0.39	66% 66% 10%
EBIT (Operating Income) EBIT	-13 -13	10% 10% -344%
Net Profit	-46 -46	270% 270% -1,219%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Applied DNA Sciences, Inc. Stock News

Neutral

Accesswire

●

6 days ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

- Conducts 27% Workforce Reduction, Ceases Operations at Applied DNA Clinical Labs, Positions LineaRx for Growth - STONY BROOK, NY / ACCESS Newswire / June 30, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx. As part ...

Neutral

Accesswire

●

19 days ago

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

President and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that Chairperson and Chief Executive Officer Dr. James A. Hayward is retiring from the Company and will step down from the B...

Neutral

Accesswire

●

20 days ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

STONY BROOK, NY / ACCESS Newswire / June 16, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal third quarter 2025 financial results in mid-August 2025. In alignment with this resumption, the Company has c...

More Applied DNA Sciences, Inc. News

Company Profile

Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Head office	United States
CEO	James Hayward
Employees	47
Founded	1983
Website	adnas.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now